Showing results (191-200 of 446) with videos related to
Sort By:
Pageof 45
Expert Review of Anticancer Therapy|January 4, 2017
How clinical practice is changing the rules: the sunitinib 2/1 schedule in metastatic renal cell carcinomaSergio Bracarda, Sylvie Negrier, Jochen Casper, et al.Journal of Multimorbidity and Comorbidity|July 15, 2021
A protocol for the evaluation of the process and impact of embedding formal and experiential Public and Patient Involvement training in a structured PhD programmeLouise Foley, Bridget Kiely, Aisling Croke, et al.Journal of Migration and Health|March 31, 2025
Prevalence of psychological distress detected by the PROTECT and PHQ4 questionnaires and subsequent mental health diagnosis. A cross sectional analysis of the outcomes of new arrival health assessments for refugees and asylum seekers in IrelandBridget Kiely, James Larkin, Kathryn Mullan, et al.Diabetic Medicine : a Journal of the British Diabetic Association|January 25, 2023
Hyperglycaemia following immune checkpoint inhibitor therapy-Incidence, aetiology and assessmentKaenat Mulla, Sheima Farag, Benedict Moore, et al.BMJ Open|September 3, 2021
Prevalence and predictors of medication non-adherence among people living with multimorbidity: a systematic review and meta-analysisLouise Foley, James Larkin, Richard Lombard-Vance, et al.Nature Medicine|May 27, 2021
Cytokine release syndrome in a patient with colorectal cancer after vaccination with BNT162b2Lewis Au, Annika Fendler, Scott T C Shepherd, et al.Research in Social & Administrative Pharmacy : RSAP|March 22, 2025
The association between multimorbidity and out-of-pocket expenditure for prescription medicines among adults in Denmark: A population-based register studyJames Larkin, Susan M Smith, Line Due Christensen, et al.European Journal of Cancer (Oxford, England : 1990)|July 11, 2024
"Symptomatic" melanoma brain metastases: A call for clear definitions and adoption of standardized toolsEmilie Le Rhun, Michael Weller, Carey Anders, et al.European Urology|August 14, 2022
The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs-Part B: Prostate and Urinary Tract TumorsGeorge J Netto, Mahul B Amin, Daniel M Berney, et al.JAMA Oncology|July 17, 2015
Efficacy and Safety of Nivolumab in Patients With BRAF V600 Mutant and BRAF Wild-Type Advanced Melanoma: A Pooled Analysis of 4 Clinical TrialsJames Larkin, Christopher D Lao, Walter J Urba, et al.Pageof 45